March 14, 2022 |
In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.
The specific habits of doctors around internet use are, just like the rest of us, continually evolving. For the pharmaceutical industry to effectively engage with doctors it is therefore important to keep on top of the latest trends around how they are using digital channels.
We recently conducted fresh research to address some simple questions around how often doctors are online, where they like to spend time, what types of information they are broadly looking for and what they are specifically seeking out with regards to pharmaceutical products. A total of 1,008 UK GPs took part in the omnibus survey, which was conducted by medeConnect, and their responses are analysed in this essay.
To read the full report click here.
This content was provided by M3 (EU)
Latest Content from M3 (EU)
M3 EU recently surveyed 400 pharma marketers in the UK, Germany, France and Switzerland, and here’s what we heard: Budgets are shrinking, targets are climbing, and compliance requirements are getting…
Learn more about targeted personas for HCP marketing. If pharma companies want to differentiate themselves against their competition and produce impactful results they must be much bolder than the current state…
Pharmaceutical companies know doctors want high-value educational content. In a highly pressurised, cost-constrained healthcare environment with increasing demands for value and improved patient outcomes, time-poor doctors are calling out for…
Embedding a digital strategy as a prominent part of a pharmaceutical marketing campaign is becoming ever more important. Despite some perceived reluctance on the part of the industry, pharmaceutical companies…
In our recent research piece, Doctor networks: The rules of engagement for pharma, some overarching principles for online engagement between the pharmaceutical industry and doctors were defined.
More than 80% of European doctors agree they are interested in staying up-to-date with new developments about pharmaceutical products. But what influences their choice of treatment and how do they…
M3, Inc. (Headquarters: Tokyo, Japan; CEO: Itaru Tanimura; URL: https://corporate.m3.com/; “M3” below) has announced the acquisition of MirVracha LCC (Headquarters: Moscow, Russia; CEO: Shotaro Yamamoto; “MirVracha” below), a website provider…
Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver…
Healthcare is changing. By understanding the needs of the physicians, and using innovative channels to make meaningful connections, pharma can ensure it continues to enjoy a mutually beneficial relationship.
M3 is strengthening and growing its global operations with the acquisition of Vidal Group, a trusted provider of prescribing information and clinical decision support services to doctors and other HCPs…
